STENTiT Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
11
STENTiT General Information
Description
Developer of bioresorbable vascular implants designed to reconstruct arteries and restore blood flow through natural tissue regeneration. The company offers resorbable fibrillated scaffold technology, temporary arterial support, cell infiltration mechanisms, tissue reconstruction capabilities, and gradual implant resorption, enabling cardiovascular patients and healthcare providers to achieve improved vascular restoration outcomes.
Contact Information
Website
www.stentit.comCorporate Office
- High Tech Campus 10
- 5656 AE Eindhoven
- Netherlands
Corporate Office
- High Tech Campus 10
- 5656 AE Eindhoven
- Netherlands
STENTiT Timeline
STENTiT Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | 18-Apr-2025 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Later Stage VC | 17-Jul-2024 | Completed | Generating Revenue | |||
| 6. Grant | 02-Mar-2023 | Completed | Generating Revenue | |||
| 5. Seed Round | 15-Apr-2022 | Completed | Generating Revenue | |||
| 4. Grant | 15-Aug-2019 | Completed | Generating Revenue | |||
| 3. Grant | 06-Jun-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 07-Sep-2016 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2015 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
STENTiT Comparisons
Industry
Financing
Details
STENTiT Competitors (2)
One of STENTiT’s 2 competitors is Endospan, a Formerly VC-backed company based in Herzliya, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Endospan | Formerly VC-backed | Herzliya, Israel | ||||
| Heart Medical Europe | Private Equity-Backed | Best, Netherlands |
STENTiT Patents
STENTiT Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025252642-A1 | Fibrillated construct for extraluminal connection | Pending | 02-Jun-2024 | ||
| EP-4801416-A1 | Fibrillated mesh for a medical implant and medical implant including the same | Pending | 31-Oct-2023 | ||
| WO-2025093685-A1 | Fibrillated mesh for a medical implant and medical implant including the same | Inactive | 31-Oct-2023 | ||
| JP-2024539473-A | Method for preforming an implantable polymeric luminal support structure - patents.com | Pending | 24-Nov-2021 | ||
| EP-4186477-A1 | Method of preforming an implantable polymeric endoluminal support structure | Pending | 24-Nov-2021 | A61F2/9522 |
STENTiT Signals
STENTiT Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Horizon Europe | Not-For-Profit Venture Capital | |||
| Brabantse Ontwikkelings Maatschappij | Venture Capital | Minority | ||
| Mibiton | Venture Capital | Minority |
STENTiT FAQs
-
When was STENTiT founded?
STENTiT was founded in 2015.
-
Where is STENTiT headquartered?
STENTiT is headquartered in Eindhoven, Netherlands.
-
What is the size of STENTiT?
STENTiT has 13 total employees.
-
What industry is STENTiT in?
STENTiT’s primary industry is Therapeutic Devices.
-
Is STENTiT a private or public company?
STENTiT is a Private company.
-
What is STENTiT’s current revenue?
The current revenue for STENTiT is .
-
How much funding has STENTiT raised over time?
STENTiT has raised $1.98M.
-
Who are STENTiT’s investors?
MedTech Innovator, European Innovation Council, Horizon Europe, Brabantse Ontwikkelings Maatschappij, and Mibiton are 5 of 11 investors who have invested in STENTiT.
-
Who are STENTiT’s competitors?
Endospan and Heart Medical Europe are competitors of STENTiT.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process